The FDA approved a pressured, metered-dose inhaler containing albuterol and budesonide (Airsupra) for treating adults with asthma, drugmaker AstraZeneca announced.. The combination, formerly known ...

Hospitals across the U.S. face shortages of the drug albuterol, used to treat respiratory illnesses. Supplies of the drug were reduced over a fall and winter by patients with RSV, influenza and ...

The metered dose inhalers may be used by adults and children ages 4 years and older, and the oral tablets are approved for ...

The FDA’s Pulmonary-Allergy Drug Advisory Committee voted 16-1 in favor of approving the fixed-dose combination of budesonide and albuterol sulfate metered dose inhaler for patients with asthma ...

The FDA approved a pressurized metered-dose inhaler with a fixed-dose combination of albuterol and budesonide for use as rescue medication among patients with asthma aged 18 years and older ...

As AstraZeneca fights to defend its aging two-drug inhaler Symbicort against generics, the company has a new approval to bolster its respiratory business. Wednesday, the British drugmaker said the ...